REM Sleep Behavior Disorder as a Prodromal Synucleinopathy: Updates on Clinical and Laboratory Biomarkers, and Implications for Neuroprotective Trials.

Neilson LE, Khattab YI, Lim MM

Open source

DOI
10.1007/s11910-025-01452-4
Published
2025 Oct 24
Container
Current neurology and neuroscience reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11910-025-01452-4,
  title = {REM Sleep Behavior Disorder as a Prodromal Synucleinopathy: Updates on Clinical and Laboratory Biomarkers, and Implications for Neuroprotective Trials.},
  author = {Neilson LE and Khattab YI and Lim MM},
  year = {2025},
  journal = {Current neurology and neuroscience reports},
  doi = {10.1007/s11910-025-01452-4},
  url = {https://doi.org/10.1007/s11910-025-01452-4}
}

RIS

TY  - JOUR
TI  - REM Sleep Behavior Disorder as a Prodromal Synucleinopathy: Updates on Clinical and Laboratory Biomarkers, and Implications for Neuroprotective Trials.
AU  - Neilson LE
AU  - Khattab YI
AU  - Lim MM
PY  - 2025
JO  - Current neurology and neuroscience reports
DO  - 10.1007/s11910-025-01452-4
UR  - https://doi.org/10.1007/s11910-025-01452-4
ER  - 

APA

LE, N., YI, K., & MM, L. (2025). REM Sleep Behavior Disorder as a Prodromal Synucleinopathy: Updates on Clinical and Laboratory Biomarkers, and Implications for Neuroprotective Trials.. Current neurology and neuroscience reports. https://doi.org/10.1007/s11910-025-01452-4

Source records